Advertisement

Organisation › Details
Merck (DE) (Group)
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2017, Merck generated sales of €15.3 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. *
![]() |
Start | 1668-01-01 established_pre |
![]() |
Industry | pharmaceutical |
Industry 2 | reagents (bio/biochemical) | |
![]() |
Person | Oschmann, Stefan (Merck (DE) 201604– CEO before Executive Board Member since 2011 before MSD) |
Person 2 | Kuhnert, Marcus (Merck (DE) 201408– CFO before CFO of Henkel Laundry + Home Care businss unit) | |
![]() |
Region | Darmstadt |
Country | Germany | |
Street | 250 Frankfurter Str. | |
City | 64293 Darmstadt | |
Tel | +49-6151-72-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | I: 50,001 to 100,0 (2018-12-31) |
Currency | EUR | |
Annual sales | 14,836,000,000 (sales, net, consolidated (2018) 2018-12-31) | |
Profit | 3,396,000,000 (2018-12-31) | |
Cash | 2,170,000,000 (2018-12-31) | |
* Document for �About Section�: Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt. | ||
Record changed: 2020-10-18 |
Advertisement

More documents for Merck (DE) (Group)
- [1] Merck KGaA. (1/8/21). "Press Release: Merck Announces Formation of Merck Digital Ethics Advisory Panel". Darmstadt....
- [2] Merck KGaA. (1/7/21). "Press Release: Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics". Darmstadt....
- [3] Merck KGaA. (12/7/20). "Press Release: Merck Expands Life Science Production Capacities in the United States". Darmstadt....
- [4] Merck KGaA. (12/3/20). "Press Release: Merck and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology". Darmstadt....
- [5] Flagship Pioneering. (11/16/20). "Press Release: Flagship Pioneering Announces Appointment of Dr. Luciano Rossetti as New Chief Medical Officer". Cambridge, MA....
- [6] Merck KGaA. (11/9/20). "Press Release: Merck Announces Out-licensing Agreement for Investigational Atacicept with Vera Therapeutics [Not intended for UK and US based media]". Darmstadt....
- [7] Merck KGaA. (10/12/20). "Press Release: Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA". Darmstadt....
- [8] Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD....
- [9] Merck KGaA. (10/8/20). "Press Release: Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant". Darmstadt....
- [10] Merck KGaA. (10/6/20). "Press Release: Merck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis [Not intended for UK and US based media]". Darmstadt....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top